Roland Andersson & Thomas Krohn: Transcelerate BioPharma Initiative

Transcelerate BioPharma Initiative In this 4-minute audio snippet, Roland Andersson, Director for Accenture’s Life Sciences R&D practice, and Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly, discuss the Transcelerate Biopharma initiative, the goals of which are to increase compliance and the productivity of clinical trials.

Your browser does not support the audio element. Upgrade your browser to one that does

You can hear the full interview of Roland Andersson and Thomas Krohn and colleagues here:

POPULAR CATEGORY

The Pharma Marketing Network® was established in 2003 by John Mack (aka Pharmaguy). Our ongoing mission is to continue the work John started; speaking truth to power, asking tough questions, and building this ever-growing community of conscientious professionals.